首页> 中文期刊> 《医学理论与实践》 >超高N-末端脑利钠肽值(NT-proBNP)和心率震荡(HRT)对心衰患者临床价值的分析

超高N-末端脑利钠肽值(NT-proBNP)和心率震荡(HRT)对心衰患者临床价值的分析

         

摘要

目的:测定老年慢性心衰患者的血浆N-末端脑钠素前体(NT-pro BNP)和心率震荡(HRT)水平,探讨血浆NT-Pro BNP和HRT值对心衰的临床价值的评估。方法:选择本院住院心力衰竭(CHF)的住院患者80例组成,其中男、女比例不限;对照组80例,为心功能正常者。两组年龄、性别差异无显著意义( P>0.05),具有可比性。心衰患者测定NT-pro BNP>5000pg/ml和TS≤3.0的患者。分为好转组和死亡组。随访1年。两组比较分析。结果:老年CHF患者与老年健康者NT-pro BNP、窦性 HRT 存在明显差别(P<0.05);老年CHF组NT-pro BNP(4967.04±366.16)pg/ml明显高于对照组(416.21±146.54)pg/ml(P<0.001);老年CHF组TO(0.76±3.42)明显高于对照组(-1.61±2.05)(P<0.05);老年CHF组TS(2.53±1.21)明显低于对照组(9.56±4.03)(P<0.05)。老年CHF组LVEF(38.37±12.15)%明显低于对照组的(66.52±13.05)%(P<0.05)。结论:慢性心衰患者的 NT-pro BNP>5000pg/ml和TS≤3.0死亡率高。%Determination of plasma N-terminal pro brain natriuretic peptide in elderly patients with chronic heart failure (NT-pro BNP) body and heart rate turbulence (HRT ) level ,evaluation of plasma NT-pro BNP and HRT clinical value of the heart failure .Methods :The hospitalized heart failure (CHF) of 80 cases of patients ,male ,female ra-tio is not restricted ;control group :80 patients ,for patients with normal cardiac function .No significant gender differ-ences in two age groups ,(P> 0 .05) ,with comparable .Determination of NT-pro BNP ,5 000pg/ml in patients with heart failure and TS ≤ 3 patients .Divided into improved group and death group .1 year of follow-up .Comparative a-nalysis of two groups .Results:In elderly CHF patients and healthy elderly subjects NT-pro BNP ,sinus HRT significant differences (P<0 .05);elderly group CHF NT-pro BNP(4 967 .04 ± 366 .16)pg/ml was significantly higher than the control group (416 .21 ± 146 .54)pg/ml(P< 0 .001);aged CHF group TO(0 .76 ± 3 .42) was significantly higher than that of control group (-1 .61 ± 2 .05) (P<0 .05);aged CHF group TS (2 .53 ± 1 .21) was significantly lower than that of the control group (9 .56 ± 4 .03) (P<0 .05) .The aged CHF group LVEF (38 .37 ± 12 .15)% was significantly lower than that of the control group (66 .52 ± 13 .05)% (P<0 .05) .Conclusion :In patients with chronic heart failure NT-pro BNP ,5 000pg/ml and TS≤ 3 high mortality .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号